Chrysler column recall — NHTSA campaign 23V352000
Chrysler (FCA US, LLC) is recalling certain 2022-2023 Jeep Grand Cherokee and 2021-2023 Jeep Grand Cherokee L vehicles. An incorrectly assembled steering column intermediate shaft may…
Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
Chrysler (FCA US, LLC) is recalling certain 2022-2023 Jeep Grand Cherokee and 2021-2023 Jeep Grand Cherokee L vehicles. An incorrectly assembled steering column intermediate shaft may…
Presence of Foreign Substance: Glass splinter particle entrapped inside the pump ball seat rendered the pump inoperable.
Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.
Product mixup: one foreign tablet found in product.
Ford Motor Company (Ford) is recalling certain 2020-2023 Explorer, Lincoln Aviator, and 2020-2022 Lincoln Corsair vehicles equipped with a 360-degree camera. The video output may fail,…
General Motors, LLC (GM) is recalling certain 2020-2023 Chevrolet Equinox and GMC Terrain vehicles. The four rear-seat lower child seat LATCH anchorage bars may have excessive powder…
Chrysler (FCA US, LLC) is recalling certain 2022-2023 Jeep Grand Cherokee L and Grand Cherokee vehicles. The air bag warning label may be missing from the dashboard. As such, these vehicles…
CGMP deviation: product outside labeled storage temperature requirements.
Superpotent Drug and Failed Impurities/Degradation Products: formula does not adhere to the labeled specifications
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of…
CGMP deviation: product outside labeled storage temperature requirements.
Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating, each tablet contains instead of each adhesive…
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of…
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of…
CGMP deviation: product outside labeled storage temperature requirements.
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
CGMP Deviations
Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.
Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.
Presence of Particulate Matter: A piece of glass was found in a prefilled syringe.
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
CGMP Deviations
Browse recent months with enough recall history for useful comparison.